Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mitotic Kinesin-Like Protein 1 (MKLP1/KIF23) in hereditary congenital dyserythropoietic anemia type III and in cancer
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Medical and Clinical Genetics. (Irina Golovleva)
2021 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

A hereditary form of autosomal dominant congenital dyserythropoietic anaemiatype III (CDA III) has been reported in four families from Sweden, Argentina, Cuba and USA. CDA III patients might experience signs of mild anaemia and some of them need occasional blood transfusions. Other clinical features seen in CDA III patients are retinal angioid streaks, monoclonal gammopathy of undetermined significance and multiple myeloma. Their bone marrow is characterised by presence of giant erythroblasts with up to 12 nuclei. Previously, CDA III was mapped to a region on chromosome 15q21-q25.

In this study we aimed to identify the genetic cause of CDA III, investigate the reasons why erythroid lineage in the patients’ bone marrow is mostly affected, and seek the explanation of increased rate of cancer in the Swedish CDA III family.

We identified the genetic cause of CDA III using targeted next generation sequencing. A novel missense mutation c.2747C>G, p.P916R in kinesin familymember 23 gene (KIF23) segregated with the disease in both the American and Swedish family, and was absent in databases of sequence variants from healthy individuals. Knock-down and rescue experiments in HeLa Kyoto cells showed that the P916R mutation caused cytokinesis failure which resulted in large cells with several nuclei. This was consistent with the CDA III phenotype.

To reveal interaction partners of wild-type and mutant KIF23 proteins, pull-down experiments followed by mass spectrometry and Western blot analysis were performed. This identified Coatomer Protein Complex I (COPI), a vesicle forming complex responsible for intracellular transport, as a KIF23 interactor. By using immunofluorescence and fluorescence microscopy, we showed that COPI subunits COPα and COPβ localize to the midbody during cytokinesis. These findings indicate involvement of vesicle transport proteins in mitosis and cytokinesis, though the significance of COPI-KIF23 interaction in cell division remains to be uncovered.

To address the question if other cells are affected by the KIF23 P916R mutation, we created a knock-in mouse model with Kif23 c.2726C>G, p.P909R, which corresponds to the human KIF23 c.2747C>G. However, the mice did not developany phenotype indicating CDA III. This result was consistent with the studies ofother CDA subtypes where mouse models failed, suggesting that CDA occur only in humans. Our study of human and mouse KIF23/Kif23 expression revealed novel, previously not annotated transcripts, one in human and two in mice. Expression analysis of total mRNA using droplet digital PCR demonstrated an extensive variation of KIF23 and Kif23 expression levels in all tissues. The shortest Kif23 transcript lacking exon 17 and 18 was prevalent in mice, while corresponding transcript in human was the least expressed.

Considering the importance of KIF23 in cytokinesis and KIF23 association with cancer, we hypothesized that somatic KIF23 mutations might be overrepresented in cancer. For this purpose, we screened KIF23 and its promoter in non-small cell lung cancer samples that previously demonstrated KIF23 overexpression. No pathogenic driving KIF23 variants were detected by Sangersequencing; however, subsequent genome-wide genotyping (SNP-array) detected gain of chromosome 15 in most cases that could possibly explain KIF23 overexpression.

Place, publisher, year, edition, pages
Umeå: Umeå Universitet , 2021. , p. 59
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2117
Keywords [en]
Alternative splicing, Cell division, COPI, Congenital dyserythropoietic anemia, Cytokinesis, Gene expression, KIF23 protein human, Cancer, MKLP1 protein mouse, Mutation
National Category
Medical Genetics
Research subject
Medical Genetics
Identifiers
URN: urn:nbn:se:umu:diva-179788ISBN: 978-91-7855-470-6 (print)ISBN: 978-91-7855-471-3 (electronic)OAI: oai:DiVA.org:umu-179788DiVA, id: diva2:1527301
Public defence
2021-03-05, Hörsal Betula, byggnad 6M, målpunkt L, Norrlands Universitetssjukhus, Umeå, 09:00 (English)
Opponent
Supervisors
Note

P.g.a. covid 19 uppmanas åhörare att delta digitalt via Zoom. Länk: https://umu.zoom.us/j/65108113265

Available from: 2021-02-12 Created: 2021-02-10 Last updated: 2021-02-10Bibliographically approved
List of papers
1. Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23
Open this publication in new window or tab >>Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23
Show others...
2013 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 121, no 23, p. 4791-4799Article in journal (Refereed) Published
Abstract [en]

Haplotype analysis and targeted next-generation resequencing allowed us to identify a mutation in the KIF23 gene and to show its association with an autosomal dominant form of congenital dyserythropoietic anemia type III (CDA III). The region at 15q23 where CDA III was mapped in a large Swedish family was targeted by array-based sequence capture in a female diagnosed with CDA III and her healthy sister. Prioritization of all detected sequence changes revealed 10 variants unique for the CDA III patient. Among those variants, a novel mutation c.2747C>G (p.P916R) was found in KIF23, which encodes mitotic kinesin-like protein 1 (MKLP1). This variant segregates with CDA III in the Swedish and American families but was not found in 356 control individuals. RNA expression of the 2 known splice isoforms of KIF23 as well as a novel one lacking the exons 17 and 18 was detected in a broad range of human tissues. RNA interference-based knock-down and rescue experiments demonstrated that the p.P916R mutation causes cytokinesis failure in HeLa cells, consistent with appearance of large multinucleated erythroblasts in CDA III patients. We conclude that CDA III is caused by a mutation in KIF23/MKLP1, a conserved mitotic kinesin crucial for cytokinesis.

Place, publisher, year, edition, pages
Washington: American Society of Hematology, 2013
National Category
Hematology
Identifiers
urn:nbn:se:umu:diva-70201 (URN)10.1182/blood-2012-10-461392 (DOI)000321895700025 ()23570799 (PubMedID)2-s2.0-84881035005 (Scopus ID)
Available from: 2013-05-07 Created: 2013-05-07 Last updated: 2023-03-23Bibliographically approved
2. Midbody recruitment of the COPI complex by centralspindlin
Open this publication in new window or tab >>Midbody recruitment of the COPI complex by centralspindlin
(English)Manuscript (preprint) (Other academic)
National Category
Cell and Molecular Biology Medical Genetics
Identifiers
urn:nbn:se:umu:diva-179787 (URN)
Available from: 2021-02-10 Created: 2021-02-10 Last updated: 2021-02-10
3. Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III
Open this publication in new window or tab >>Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III
2020 (English)In: Blood Cells, Molecules & Diseases, ISSN 1079-9796, E-ISSN 1096-0961, Vol. 85, article id 102483Article in journal (Refereed) Published
Abstract [en]

Kinesin Family Member 23 (KIF23), a cell cycle regulator, has a key task in cytokinesis. KIF23 over-expression in cancer has been associated with tumor growth, progression, and poor prognosis, indicating a potential to be a cancer biomarker. A mutation in KIF23 (c.2747C > G, p.P916R) was shown to cause congenital dyserythropoietic anemia, type III (CDA III). To-date, fifteen KIF23 transcripts have been annotated, but their expression is poorly investigated. We hypothesized that tissue specific expression of a particular transcript can be critical for CDA III phenotype. In this study, we quantified expression of alternative Kif23 transcripts in a mouse model with human KIF23 mutation and investigated its association with a regulator of alternative splicing, serine/arginine-rich splicing factor 3 (Srsf3). We confirmed presence of an additional exon 8 in both human and mouse KIF23 transcripts. A transcript lacking exons 17 and 18 was ubiquitously expressed in mice while other isoforms were common in human tissues however in bone marrow of knock-in mice a transcript without exon 18 was prevalent as it was in bone marrow of a CDA III patient. We conclude that the possibility that the tissue specific expression of KIF23 alternative transcripts influence the CDA III phenotype cannot be neglected.

Place, publisher, year, edition, pages
Elsevier, 2020
Keywords
KIF23, Srsf3, CDA III, Expression, Alternative splicing, Droplet digital PCR (ddPCR), Knock-in (KI) mice
National Category
Hematology
Identifiers
urn:nbn:se:umu:diva-175847 (URN)10.1016/j.bcmd.2020.102483 (DOI)000571001800002 ()32818800 (PubMedID)2-s2.0-85089430369 (Scopus ID)
Available from: 2020-10-15 Created: 2020-10-15 Last updated: 2023-03-24Bibliographically approved
4. Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression
Open this publication in new window or tab >>Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression
Show others...
2017 (English)In: OncoTargets and Therapy, ISSN 1178-6930, Vol. 10, p. 4969-4979Article in journal (Refereed) Published
Abstract [en]

KIF23 was recently suggested to be a potential molecular target for the treatment of lung cancer. This proposal is based on elevated expression of KIF23 in several tumors affecting breast, lung, brain, and liver, and also on the presence of KIF23 mutations in melanoma and colorectal cancer. Recently, we identified a mutation in the KIF23 gene causing a rare hereditary form of dyserythropoietic anemia (CDA III) with predisposition to blood cancer. We suggested that KIF23 overexpression in tumors might be due to the presence of activating somatic mutations, and therefore, mutation screening of the KIF23 in 15 non-small-cell lung cancer (NSCLC) cases with elevated expression level of KIF23 was undertaken. Eight sequence variants were found in all samples. Furthermore, one variant was present in two cases, and one variant was case specific. Nine variants were previously reported while one variant lacks frequency information. Nine of ten cases available for single nucleotide polymorphism-array analysis demonstrated aberrant karyotypes with additional copy of entire chromosome 15. Thus, no activating somatic mutations in coding regions of the KIF23 were found. Furthermore, no mutations were detected in cell cycle genes homology region in KIF23 promoter responsible for p53-dependent repression of KIF23 expression. We showed that the elevated level of KIF23 could be due to additional copy of chromosome 15 demonstrated in 90% of NSCLC cases analyzed in this study. Considering the crucial role of KIF23 in the final step of mitosis, the gene is a potential molecular marker, and for better understanding of its role in cancer development, more tumors should be analyzed.

Place, publisher, year, edition, pages
DOVE MEDICAL PRESS LTD, 2017
Keywords
KIF23, overexpression, mutation, copy number alteration, CNA, lung cancer
National Category
Medical Genetics
Identifiers
urn:nbn:se:umu:diva-141225 (URN)10.2147/OTT.S138420 (DOI)000412742500004 ()2-s2.0-85031713407 (Scopus ID)
Available from: 2017-11-06 Created: 2017-11-06 Last updated: 2023-03-23Bibliographically approved

Open Access in DiVA

fulltext(1198 kB)223 downloads
File information
File name FULLTEXT02.pdfFile size 1198 kBChecksum SHA-512
629302980480435df664e568fd4f37e119f668c22334242f2013135cc5acb1706ff199f17c2deb4821631f46583cedf84751b3fcbae7045082ccb2093ac5e1e6
Type fulltextMimetype application/pdf
spikblad(170 kB)37 downloads
File information
File name SPIKBLAD01.pdfFile size 170 kBChecksum SHA-512
c1761ba45e65d69cf977e8212b8920bed49f0ce3400b8dd0ce7729066be3cf1e39b83b2f8a45f040333d25b01d6a1b66e8442fbd10e70b23b40f8d4591ca59a5
Type spikbladMimetype application/pdf

Authority records

Vikberg, Ann-Louise

Search in DiVA

By author/editor
Vikberg, Ann-Louise
By organisation
Medical and Clinical Genetics
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar
Total: 223 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 576 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf